Adirondack Trust Company’s Ginkgo Bioworks DNA Stock Holding History

Adirondack Trust Company’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$551	Hold	43	–	–	﹤0.01%	543
2026 Q2	$426	Hold	43	–	–	﹤0.01%	551
2026 Q1	$263	Hold	43	–	–	﹤0.01%	537
2025 Q4	$357	Hold	43	–	–	﹤0.01%	526
2025 Q3	$626	Hold	43	–	–	﹤0.01%	497
2025 Q2	$483	Hold	43	–	–	﹤0.01%	470
2025 Q1	$245	Hold	43	–	–	﹤0.01%	470
2024 Q4	$422	Hold	43	–	–	﹤0.01%	474
2024 Q3	$9	Hold	43	–	–	﹤0.01%	489
2024 Q2	$573	Hold	43	–	–	﹤0.01%	483
2024 Q1	$2K	Hold	43	–	–	﹤0.01%	471
2023 Q4	$2.63K	Hold	43	–	–	﹤0.01%	454
2023 Q3	$3.13K	Hold	43	–	–	﹤0.01%	436
2023 Q2	$4.35K	Hold	43	–	–	﹤0.01%	404
2023 Q1	$2.29K	Hold	43	–	–	﹤0.01%	445
2022 Q4	$2.94K	Buy	+43	New	+$3.96K	﹤0.01%	424

Other funds holding DNA

QFMHK

Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return

BSWM

Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return

TWM

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Adirondack Trust Company's DNA Position: Q3 2026 in Review

Adirondack Trust Company held its Ginkgo Bioworks (DNA) position steady in Q3 2026 at 43 shares worth $551. The position accounts for ﹤0.01% of the portfolio, ranked #543.

Adirondack Trust Company first reported a position in DNA in Q4 2022 and has held it in 16 quarters since. The position peaked at $4.35K in Q2 2023. 10 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

Adirondack Trust Company held 43 shares of Ginkgo Bioworks worth $551 as of Q3 2026.
Adirondack Trust Company left its Ginkgo Bioworks share count unchanged in Q3 2026.
Ginkgo Bioworks made up ﹤0.01% of Adirondack Trust Company's portfolio in Q3 2026, its #543 holding.
Adirondack Trust Company first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 16 quarters since.
Adirondack Trust Company's Ginkgo Bioworks position peaked at $4.35K in Q2 2023.
10 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Adirondack Trust Company's 13F filing for Q3 2026, filed 14 Oct 2026.